TrialNephrology (Carlton, Vic.)2017

Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomized, open-label, multicentre, 12-week phase III study.

Fumihiko Koiwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.